Share on: 
Website: CytoDyn

CytoDyn Inc is a biotechnology company that develops treatments based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. This antibody belongs to a new class of therapeutics called viral-entry inhibitors as it blocks the ability of HIV to bind CCR5 and enter and infect healthy T-cells. The company is currently evaluating whether leronlimab acts as a potential coronavirus drug.

Career Page(s): 
Vancouver WA
United States